OTCM
CBSTQ
Market cap0kUSD
Oct 23, Last price
0.00USD
1D
0.00%
1Q
0.00%
IPO
-100.00%
Name
Columbia Care Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Columbia Care Inc. is a company operating in the cannabis sector, engaged in the cultivation, manufacturing, and distribution of a broad array of cannabis products and associated services. The firm's product lineup includes diverse forms such as flowers, edibles, oils, and tablets, marketed under its various proprietary brands, including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD. The company holds essential licenses to conduct its operations across 18 distinct jurisdictions, encompassing territories within both the United States and the European Union. As of mid-June 2022, Columbia Care maintained an extensive operational footprint comprising 131 facilities; specifically, this included 99 retail dispensaries and 32 sites dedicated to cultivation and manufacturing processes. Columbia Care was established in 2012 and its corporate headquarters are situated in New York, New York.
Key people
Jesse Channon
President · since 2024
David Hart
Chief Executive Officer, Director · since 2024
Bryan Olson
Chief People and Administrative Officer · since 2020
David Sirolly
Chief Legal Officer and General Counsel · since 2021
Michael Abbott
Executive Chairman of the Board · since 2019
Director · since 2023
Nicholas Vita
Director · since 2024
Independent Director · since 2020
Julie Hill
Independent Director · since 2021
James Kennedy
Independent Director · since 2019
Independent Director · since 2025
Independent Director · since 2025
Jonathan May
Lead Independent Director · since 2023
Frank Savage
Independent Director · since 2020
Alison Worthington
Independent Director · since 2020
Legal address
Suite 1700, Park Place, 666 Burrard Street
Vancouver, BC V6C 2X8
CA
Vancouver, BC V6C 2X8
CA
Headquarters
680 Fifth Avenue, 24th Floor
New York 10019
US
New York 10019
US
Previous name
COLUMBIA CARE INC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||